PRESS RELEASE published on 02/06/2024 at 09:00, 2 years 2 months ago AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin AATec Medical collaborates with German Federal Agency for Disruptive Innovation SPRIND to develop ATL-105, a recombinant alpha-1 antitrypsin platform for respiratory diseases, including viral infections and inflammatory diseases Respiratory Diseases AATec Medical German Federal Agency For Disruptive Innovation SPRIND ATL-105 Recombinant Alpha-1 Antitrypsin
PRESS RELEASE published on 10/31/2023 at 10:00, 2 years 5 months ago AATec Medical and Beurer enter development collaboration for inhaled Alpha-1 Antitrypsin
PRESS RELEASE published on 10/10/2023 at 11:00, 2 years 5 months ago AATec Medical GmbH: AATec Medical Announces Creation of Scientific Advisory Board
PRESS RELEASE published on 07/17/2023 at 11:00, 2 years 8 months ago AATec Medical GmbH: AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin
Published on 04/09/2026 at 16:00, 2 hours 43 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 3 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 43 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 13 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 13 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 28 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 8 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 2 hours 45 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 43 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
